Paratek Pharmaceuticals Inc

Bank of New York Mellon Corp

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/3/2023

Shares

17,893

Value ($000)

40

Weight

0.0%

2019 Q4 - 2023 Q2 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/3/2023	40	0.0%	17,893	6/30/2023
2023 Q1	5/9/2023	45	0.0%	17,893	3/31/2023
2022 Q4	2/14/2023	33	0.0%	17,893	12/31/2022
2022 Q3	11/14/2022	46	0.0%	17,893	9/30/2022
2022 Q2	8/15/2022	39	0.0%	20,078	6/30/2022
2022 Q1	5/11/2022	407	0.0%	137,094	3/31/2022
2021 Q4	2/11/2022	616	0.0%	137,251	12/31/2021
2021 Q3	11/18/2021	682	0.0%	140,159	9/30/2021
2021 Q2	8/11/2021	869	0.0%	127,447	6/30/2021
2021 Q1	5/13/2021	920	0.0%	130,283	3/31/2021
2020 Q4	2/9/2021	825	0.0%	131,851	12/31/2020
2020 Q3	11/12/2020	721	0.0%	133,222	9/30/2020
2020 Q2	8/12/2020	748	0.0%	143,367	6/30/2020
2020 Q1	5/6/2020	379	0.0%	120,384	3/31/2020
2019 Q4	2/14/2020	486	0.0%	120,605	12/31/2019